The Curse of Late-Onset Illnesses in Men

Okay, this is a fairly long post because I'm covering a fairly big issue. And, although the focus of this site is on men's mental health, it's impossible to seperate the mind from the body when it comes to physical illness. So, let's begin.

A man arrives at the family doctor. He's typically in his late 40s, 50s or 60s — with a condition that has been developing, quietly for somewhere between six months and several years. The symptoms were there. They were noticed, in the way that a strange noise in the engine is noticed — registered, attributed to something innocuous, and filed under probably nothing.

By the time he presents, the condition is more advanced than it would have been six months earlier. The treatment options are more limited. The outcomes are less good. The doctor, maintaining the expression of someone who has not heard this particular story several times this week, begins the conversation about what happens next.

This is not a rare scenario. It is, for a depressingly wide range of conditions, the standard male presentation pattern — and understanding why it happens, what conditions it particularly affects, and what the actual consequences are is both more urgent and more interesting than the usual public health messaging about men needing to go to the doctor more.

The late presentation issue

What this article focuses on is the specific early and late quality of life. For these conditions, the male habit of waiting — of monitoring, of giving it until Christmas, of seeing how things go — is not a neutral strategy with inconvenient implications. It is a choice with a medical cost that is, in some cases, the difference between a treatable condition and one that isn't.

The conditions most affected by late male presentation fall into several categories: cancers with strong male prevalence, cardiovascular and metabolic conditions, mental health conditions already covered in other articles, and a set of conditions whose male-specific dimensions are insufficiently known and insufficiently discussed.

The cancer landscape

Cancer is the condition category in which late presentation has the most direct and most documented effect on outcome, and in which the male patterns are most clearly visible.

Prostate cancer

Prostate cancer is the most common cancer in men in the UK, with approximately 52,000 new diagnoses each year. It is also the cancer in which the tension between screening, diagnosis and treatment is most complex, and in which the male tendency to defer is most consequential.

The complexity of prostate cancer is specific: unlike some cancers, where early detection straightforwardly improves outcomes, prostate cancer exists on a spectrum from slow-growing tumours that may never cause clinical problems to aggressive cancers that require urgent treatment. The PSA test — the blood test that measures prostate-specific antigen — is the primary screening tool, and it is both imperfect and contested. It produces false positives that lead to unnecessary treatment, and it misses some cancers that the false positives don't.

This complexity has been used, understandably but somewhat problematically, as a reason not to engage with screening. The argument runs: the test isn't reliable enough, the overdiagnosis problem is real, the treatment side effects are significant, so the rational response is to wait for symptoms.

The problem is that prostate cancer in its early, most treatable stages is frequently asymptomatic. The symptoms — urinary difficulties, reduced flow, increased frequency, blood in urine or semen — tend to appear when the disease is more advanced. The man who waits for symptoms before seeking evaluation is, in a significant proportion of cases, allowing an early-stage, highly treatable condition to progress to one that is not.

In the UK, there is no national prostate cancer screening programme, which means engagement requires individual initiative rather than a postal invitation. The Prostate Cancer UK risk checker takes ten minutes and provides a personalised risk assessment. Men over 50, or over 45 with a family history, or over 45 of Black African or Black Caribbean heritage — in whom prostate cancer risk is significantly elevated — should have a conversation with their doctor about PSA testing rather than waiting for the conversation to be initiated from the other side.

Bowel cancer

Bowel cancer is the fourth most common cancer in the UK and the second most common cause of cancer death — statistics that are more alarming than they need to be, given that bowel cancer is one of the most detectable and most treatable cancers when caught early.

The NHS Bowel Cancer Screening Programme sends home testing kits — the faecal immunochemical test, or FIT test — to everyone aged 50 to 74 in England, with similar programmes in Scotland, Wales and Northern Ireland. The test is simple, takes minutes, requires no clinical contact, and can be completed entirely at home.

Uptake among men is lower than among women. The reasons are familiar from the broader literature on male health avoidance — embarrassment, the general preference for not investigating things that might reveal something unwelcome — and they are, in this context, consequential. Bowel cancer detected at stage one has a five-year survival rate of approximately 90 per cent. Detected at stage four, that figure falls below 10 per cent.

The man who leaves the screening kit unopened on the kitchen counter for three months before binning it without using it is not making a neutral decision. He is making a medical decision with a statistical implication that he almost certainly hasn't articulated to himself, because articulating it would require engaging with the exact information he is declining to receive.

The symptoms of bowel cancer worth knowing — persistent change in bowel habits, blood in stools, unexplained weight loss, abdominal pain — are symptoms that men commonly attribute to haemorrhoids, diet, or the general vicissitudes of middle age, and that commonly are those things. They are also the symptoms of bowel cancer, and the only way to distinguish between the benign explanation and the malignant one is to have them assessed rather than self-diagnosed.

Testicular cancer

Testicular cancer is the most common cancer in men aged 15 to 49 in the UK, and it is one of the most treatable cancers in existence, with overall survival rates above 95 per cent when detected early. It is also, in a pattern that requires no elaborate explanation, a cancer in which embarrassment, avoidance and the general male reluctance to engage with symptoms below the waist produce presentation delays that are both common and entirely unnecessary.

The average delay between a man first noticing a testicular lump or change and presenting to a doctor is, in UK studies, somewhere between three and six months. In a cancer with a 95 per cent survival rate at early detection, this delay is not a minor inconvenience. It is a decision to allow a highly manageable condition to potentially progress to one that is less so.

Testicular self-examination — recommended monthly, taking approximately two minutes — is the primary detection tool and requires no clinical contact, no embarrassment and no medical expertise. Testicular Cancer UK provides clear guidance. The barrier is exclusively psychological, which is both the best and most frustrating kind of barrier.

Skin cancer

Melanoma — the most serious form of skin cancer — has a male prevalence that increases significantly with age, and a male mortality rate that is disproportionately high relative to incidence, which is the statistical signature of late presentation. Men are more likely than women to develop melanoma on the back — an area that requires external detection — and significantly less likely to notice changes or to present when they do.

The ABCDE rule for melanoma detection — Asymmetry, Border irregularity, Colour variation, Diameter over 6mm, Evolution or change — is the standard self-assessment framework, and it works well as a detection tool for people who actually use it. The British Skin Foundation provides accessible guidance on self-examination. The American Academy of Dermatology provides equivalent US resources.

Cardiovascular disease

Cardiovascular disease remains the leading cause of death in men in the UK, a position it has held with depressing consistency for decades. It is also a condition category in which the gap between what is known about prevention and detection and what men actually do about it is perhaps the widest in all of medicine.

The relevant late-onset dimension here is not simply that heart disease develops with age — which it does, through the gradual accumulation of arterial damage from hypertension, elevated cholesterol, smoking, sedentary behaviour, poor diet and metabolic dysfunction — but that the warning signals of cardiovascular risk are frequently present years before the event and are frequently not acted upon.

Hypertension — high blood pressure — is present in approximately one in three adults in the UK and is asymptomatic in the majority of cases. It is detectable through a blood pressure measurement that takes thirty seconds and is available at every doctor's surgery, most pharmacies and many supermarkets. It is known as the silent killer, not because it is particularly mysterious but because it does its damage — to blood vessels, to the heart, to the kidneys, to the brain — without announcing itself through symptoms, and because the men in whom it is present tend not to be having it measured at the frequency that would allow early detection and management.

The NHS Health Check — available to adults aged 40 to 74 every five years — assesses blood pressure, cholesterol, blood sugar, BMI and other cardiovascular risk factors, and produces a cardiovascular risk score that informs both lifestyle and medication decisions. In England, it is a free NHS service. Uptake among men is lower than among women. The reasons are familiar.

Type 2 diabetes, which is both a consequence and a driver of cardiovascular risk, follows a similar pattern: it develops over years, is frequently asymptomatic in its early stages, is detectable through a simple blood test, and is significantly more manageable when detected early than when it presents through its complications — neuropathy, retinopathy, nephropathy, cardiovascular disease — which is how it commonly presents in men who haven't been monitored.

The sleep apnoea oversight

Obstructive sleep apnoea — in which the upper airway partially or completely collapses during sleep, producing repeated brief arousals, fragmented sleep and oxygen desaturation — is estimated to affect approximately 1.5 million adults in the UK, of whom the majority are undiagnosed. It is significantly more common in men, in those over 40, and in those with central obesity.

Its consequences extend considerably beyond disrupted sleep. Untreated sleep apnoea is associated with elevated cardiovascular risk, hypertension, type 2 diabetes, depression, cognitive impairment, and — in a finding that tends to concentrate attention — significantly elevated risk of road traffic accidents among those driving while chronically sleep-deprived.

The presenting symptom most commonly described by the partners of men with sleep apnoea is snoring with observed pauses in breathing — a symptom that the man himself is, by definition, asleep for and therefore unaware of. The daytime symptoms — excessive sleepiness, difficulty concentrating, morning headaches, irritability — are commonly attributed to working too hard, not sleeping enough, or simply getting older.

The diagnosis is straightforward — a home sleep study or a referral to a sleep clinic — and the primary treatment, CPAP therapy, is highly effective when used consistently. The barrier is, again, the male tendency to attribute symptoms to benign causes and defer investigation indefinitely.

The British Snoring and Sleep Apnoea Association provides accessible symptom guidance and information on the diagnostic pathway.

Hearing loss

Age-related hearing loss — presbycusis — affects approximately one in three people over 65 and one in two over 75, and is both more prevalent in men than women and more commonly left unaddressed.

The consequences of untreated hearing loss are not merely auditory inconvenience. The research on hearing loss and cognitive health is consistent and concerning: untreated hearing loss is associated with significantly elevated risk of cognitive decline and dementia, through mechanisms that include both the increased cognitive load of effortful listening and the social isolation that hearing difficulty tends to produce.

The hearing aids that address the condition have improved beyond recognition in the past decade — smaller, more effective, more natural in their acoustic presentation than the devices of twenty years ago — and the NHS provides them free. The barrier is the identification of the loss itself, which tends to be gradual enough to be accommodated through increased volume, requests to repeat, and the general social adaptations that constitute the hearing-impaired man's experience before anyone uses the word audiologist.

The RNID (Royal National Institute for Deaf People) provides a free online hearing check and guidance on accessing NHS audiology services.

Mental health: a brief cross-reference

The late presentation pattern in mental health conditions in men is covered extensively in the article on what depression looks like in men, and the mechanisms are the same as those operating in physical health avoidance — the identity threat, the cultural script around self-sufficiency, and the misattribution of symptoms to physical causes.

The relevant addition here is the specific pattern of late mental health presentation in the context of physical illness. Men diagnosed with serious physical conditions — cancer, cardiovascular disease, chronic illness — have significantly elevated rates of depression and anxiety, and are significantly less likely to have these identified and treated than women in the same clinical situation. The oncology department or the cardiac ward is treating the presenting condition; the psychological impact of it is treated by nobody, because nobody has asked, and the man hasn't said.

The integrated care argument — treating the psychological and physical dimensions of illness simultaneously — has a robust evidence base and a slow rate of implementation. In its absence, the practical recommendation is to raise the psychological dimension explicitly when dealing with any serious physical diagnosis, rather than assuming it will be addressed unless volunteered.

The family history conversation

One of the more underused tools in late-onset illness prevention is the family history — the knowledge of what conditions affected parents, grandparents and siblings, which provides both a genetic risk profile and a set of symptoms to watch for with particular attention.

Men are significantly less likely than women to have gathered, retained or acted on family medical history, for reasons that are partly about communication style — the paternal side of family medical history is frequently undocumented because the men in previous generations didn't discuss their health — and partly about the general male preference for not engaging with information that might require action.

The family history conversation — with parents where possible, with siblings, with the family doctor — is a low-cost, high-value investment in early detection. The man whose father had bowel cancer, whose grandfather had cardiovascular disease, and whose uncle had prostate cancer is not operating with the same risk profile as one without those histories, and his surveillance should reflect that rather than defaulting to the population average.

The compounding problem

The specific cruelty of late-onset illness in men is not that individual conditions are worse than they need to be — though they are — but that the conditions tend to compound. The man with untreated hypertension, undiagnosed sleep apnoea, unmanaged metabolic risk, untreated depression and a deferred skin lesion is not carrying four separate, independent problems. He is carrying an interconnected cluster of conditions that each make the others worse, and that become progressively harder to manage the longer the cluster remains unaddressed.

The weekly reset article describes the psychological cost of unaddressed accumulation in ordinary life. The medical version of this is more serious: the accumulation of unmanaged physical health risk compounds across years, and the cost of managing a cluster of advanced conditions simultaneously is higher — in outcome, in treatment burden, and in quality of life — than the cost of addressing each component earlier when they were more tractable.

The argument for the NHS Health Check, for regular doctor visits, for completing the bowel screening, for the PSA conversation, for the hearing test, for the skin check — the argument for all of it is not primarily about any single condition. It is about not arriving, at 62, with a list of things that should have been addressed at 52 and weren't, and that are now considerably more complicated than they needed to be.

What to actually do

The practical implications are not complicated, and they do not require a dramatic overhaul of lifestyle or an overnight conversion to the kind of man who books health appointments proactively. They require, more modestly, a decision that the default strategy of waiting and hoping is no longer the one you're running.

In the UK:

Book the NHS Health Check if you're 40 to 74 and haven't had one in the past five years. It is free, it takes thirty minutes, and it produces a cardiovascular risk profile that is considerably more useful than a self-assessment.

Complete the bowel screening test when it arrives. If you're over 50 and haven't received one, contact your GP surgery.

Ask your GP about PSA testing if you're over 50, or over 45 with relevant risk factors. The conversation about whether to test is worth having.

Have your blood pressure checked. At the GP, at a pharmacy, at the supermarket machine you walk past every week — anywhere that produces a number rather than an assumption.

Check your hearing if you've noticed changes, or if people keep repeating themselves at a frequency that suggests a pattern.

Look at your skin, or ask someone else to look at the parts you can't see.

In the US:

The American Heart Association provides cardiovascular risk assessment tools. Insurance permitting, the annual wellness visit is the primary vehicle for the kind of routine monitoring described above.

Before you go

The conditions described in this article share a common feature: they are significantly more manageable when addressed early than when they present late, and the gap between early and late is, in most cases, produced not by biology but by behaviour.

The man who turns up at the doctor with a symptom he noticed six months ago is not unlucky. He is experiencing the predictable consequence of a decision — or rather, a series of non-decisions — that had a medical implication he didn't factor in at the time.

The body is not trying to ambush you. It is sending signals in the only language available to it. The question is whether you are listening, and whether you are doing something with what you hear.

The doctor's waiting room is less uncomfortable than the alternative. This is not a particularly elegant argument for engaging with healthcare, but it is an accurate one, and accuracy is what this site runs on.